Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: BLL003
MIFTS: 51

Bell's Palsy

Categories: Eye diseases, Infectious diseases, Neuronal diseases, Rare diseases
Genes Variations Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Bell's Palsy

About this section

MalaCards integrated aliases for Bell's Palsy:

Name: Bell's Palsy 12 74 52 53 42 15 17
Bell Palsy 12 52 43 71 32
Facial Palsy 52 29 6
Facial Paralysis 52 71
Facial Cranial Nerve Paralysis 52
Idiopathic Facial Palsy 52
Refrigeration Palsy 52
Facial Nerve Palsy 52
Bell's Palsy 12
Antoni's Palsy 52

Classifications:

MalaCards categories:
Global: Rare diseases Infectious diseases
Anatomical: Neuronal diseases Eye diseases
See all MalaCards categories (disease lists)
ICD10: 32


External Ids:

Disease Ontology 12 DOID:12506
ICD9CM 34 351.0
MeSH 43 D020330
SNOMED-CT 67 193093009
ICD10 32 G51.0
UMLS 71 C0015469 C0376175
Sources

Summaries for Bell's Palsy

About this section
NINDS : 53 Bell's palsy is a form of temporary facial paralysis resulting from damage or trauma to the 7th cranial nerve, one of the facial nerves. It is the most common cause of facial paralysis. Generally, Bell's palsy affects only one side of the face, but it can affect both sides. Symptoms vary among individuals and include sudden weakness on one side of the face, drooping eyelid or corner of the mouth, drooling, inability to close the eye or mouth, altered taste, and excessive tearing in the eye. Symptoms appear suddenly and reach their peak within 72 hours. Bell's palsy can range in severity from mild weakness to total paralysis, and can cause significant facial distortion. The exact cause of Bell's palsy isn't known, but many scientists believe that reactivation of a dormant viral infection can cause the facial nerve to swell and become inflamed. Several other conditions can cause facial paralysis that might be diagnosed as Bell's palsy. The disorder can affect anyone at any age. Risk factors include pregnancy, preeclampsia, obesity, hypertention, diabetes, and upper respiratory ailments.

MalaCards based summary : Bell's Palsy, also known as bell palsy, is related to mastoiditis and mononeuritis multiplex, and has symptoms including seizures, muscle weakness and generalized muscle weakness. An important gene associated with Bell's Palsy is HS1BP3 (HCLS1 Binding Protein 3), and among its related pathways/superpathways are NF-kappaB Signaling and Allograft rejection. The drugs Prednisolone phosphate and Methylprednisolone have been mentioned in the context of this disorder. Affiliated tissues include eye, testes and bone.

Disease Ontology : 12 A facial paralysis resulting from dysfunction in the cranial nerve VII (facial nerve).

NIH Rare Diseases : 52 Bell's palsy is a form of temporary facial paralysis which results from damage or trauma to one of the facial nerves. This disorder is characterized by the sudden onset of facial paralysis that often affects just one side and can cause significant facial distortion. Symptoms vary, but may include twitching, weakness, drooping eyelid or corner of the mouth, drooling, dry eye or mouth, impairment of taste, and excessive tearing in the eye. While the exact cause is unknown, many researchers believe that a virus may lead to swelling of the 7th cranial nerve. Steroids, such as prednisone , may reduce the inflammation and swelling. Other medications used to treat Bell's palsy include acyclovir (to fight viral infections) and aspirin, acetaminophen, or ibuprofen (to relieve pain). Physical therapy , facial massage and acupuncture have also been used.

MedlinePlus : 42 Bell's palsy is the most common cause of facial paralysis. It usually affects just one side of the face. Symptoms appear suddenly and are at their worst about 48 hours after they start. They can range from mild to severe and include Twitching Weakness Paralysis Drooping eyelid or corner of mouth Drooling Dry eye or mouth Excessive tearing in the eye Impaired ability to taste Scientists think that a viral infection makes the facial nerve swell or become inflamed. You are most likely to get Bell's palsy if you are pregnant, diabetic or sick with a cold or flu. Three out of four patients improve without treatment. With or without treatment, most people begin to get better within 2 weeks and recover completely within 3 to 6 months. NIH: National Institute of Neurological Disorders and Stroke

Wikipedia : 74 Bell's palsy is a type of facial paralysis that results in an inability to control the facial muscles on... more...

Sources

Related Diseases for Bell's Palsy

About this section

Diseases related to Bell's Palsy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 923)
# Related Disease Score Top Affiliating Genes
1 mastoiditis 30.5 CD40LG CD4
2 mononeuritis multiplex 30.4 PMP22 CD40LG CD4
3 syphilitic meningitis 30.3 CD40LG CD4
4 mumps 30.3 MX1 IL2RA IFNA1 CD40LG
5 chickenpox 30.3 IFNA1 CD8A CD40LG CD4
6 facial paralysis 30.3 MTRNR2L5 MARVELD1 LIPN HOXB1 FKBP4 CD8A
7 herpes zoster 30.3 IFNA1 CD8A CD40LG CD4
8 asymptomatic neurosyphilis 30.2 CD40LG CD4
9 exanthema subitum 30.1 CD40LG CD4
10 plexopathy 30.1 PMP22 CD40LG
11 hairy cell leukemia 30.1 IL2RA IFNA1 CD40LG
12 tuberculoid leprosy 30.0 IL2RA CD40LG CD4
13 cranial nerve disease 30.0 MARVELD1 CD40LG CD4
14 neuroretinitis 30.0 CD40LG CD4
15 trichinosis 29.9 CD40LG CD4
16 cat-scratch disease 29.9 CD40LG CD4
17 congenital syphilis 29.9 CD40LG CD4
18 pfeiffer syndrome 29.9 CD8A CD40LG CD4
19 acquired immunodeficiency syndrome 29.8 IL2RA IFNA1 CD40LG CD4
20 aortitis 29.8 CD40LG CD4
21 syphilis 29.7 CD8A CD40LG CD4
22 poliomyelitis 29.7 CD8A CD40LG CD4
23 paranasal sinus disease 29.6 CD8A CD40LG CD4
24 viral hepatitis 29.6 MX1 IFNA1 CD40LG
25 dengue disease 29.6 IFNA1 CD8A CD40LG
26 viral infectious disease 29.6 MX1 IL2RA IFNA1 CD40LG CD4
27 stomatitis 29.6 MX1 IFNA1 CD40LG CD4
28 secondary syphilis 29.5 CD8A CD40LG CD4
29 bronchopneumonia 29.4 CD8A CD40LG CD4
30 exanthem 29.4 IFNA1 CD8A CD40LG CD4
31 pharyngitis 29.4 CD8A CD40LG CD4
32 panuveitis 29.4 CD8A CD40LG CD4
33 progressive multifocal leukoencephalopathy 29.4 CD8A CD40LG CD4
34 sarcoidosis 1 29.4 IL2RA CD8A CD40LG CD4
35 west nile encephalitis 29.4 CD8A CD40LG CD4
36 demyelinating disease 29.4 PMP22 IFNA1 CD8A CD40LG CD4
37 meningoencephalitis 29.3 CD8A CD40LG CD4
38 bacterial infectious disease 29.3 MX1 CD8A CD40LG CD4
39 neurosarcoidosis 29.3 CD8A CD4
40 severe cutaneous adverse reaction 29.3 CD8A CD40LG CD4
41 leprosy 3 29.2 PRKN CD8A CD40LG CD4
42 optic nerve disease 29.2 PRKN CD8A CD40LG CD4
43 granulomatous hepatitis 29.2 CD8A CD40LG CD4
44 miliary tuberculosis 29.2 CD8A CD40LG CD4
45 peripheral nervous system disease 29.2 PRKN PMP22 CD8A CD40LG CD4
46 xerophthalmia 29.2 MTRNR2L5 CD8A CD40LG CD4
47 parotid disease 29.1 CD8A CD40LG CD4
48 middle ear disease 29.1 CD8A CD40LG CD4
49 cellulitis 29.1 CD8A CD40LG CD4
50 epidemic typhus 29.1 CD8A CD40LG CD4

Graphical network of the top 20 diseases related to Bell's Palsy:



Diseases related to Bell's Palsy
Sources

Symptoms & Phenotypes for Bell's Palsy

About this section

UMLS symptoms related to Bell's Palsy:


seizures, muscle weakness, generalized muscle weakness, tremor, back pain, ophthalmoplegia, headache, syncope, hemiplegia, pain, chronic pain, sciatica, vertigo/dizziness, sleeplessness, oral manifestations, facial paresis, facial palsy, upper motor neuron, facial palsy, lower motor neuron, hemifacial paralysis, flaccid muscle tone
Sources

Drugs & Therapeutics for Bell's Palsy

About this section

Drugs for Bell's Palsy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 53)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Prednisolone phosphate Approved, Vet_approved Phase 4 302-25-0
2
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
3
Methylprednisolone hemisuccinate Approved Phase 4 2921-57-5
4 Prednisolone acetate Approved, Vet_approved Phase 4 52-21-1
5
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
6
Acetylcholine Approved, Investigational Phase 4 51-84-3 187
7
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
8
Prednisolone hemisuccinate Experimental Phase 4 2920-86-7
9
Cortisone Experimental Phase 4 53-06-5 222786
10 Antiemetics Phase 4
11 Gastrointestinal Agents Phase 4
12 valacyclovir Phase 4
13 Neuroprotective Agents Phase 4
14 Protective Agents Phase 4
15 Hormones Phase 4
16 Antineoplastic Agents, Hormonal Phase 4
17 Hormone Antagonists Phase 4
18 glucocorticoids Phase 4
19 Anti-Inflammatory Agents Phase 4
20 Methylprednisolone Acetate Phase 4
21 abobotulinumtoxinA Phase 4
22 Botulinum Toxins, Type A Phase 4
23 Cholinergic Agents Phase 4
24 Botulinum Toxins Phase 4
25 Neurotransmitter Agents Phase 4
26 incobotulinumtoxinA Phase 4
27 Anesthetics Phase 4
28 Sodium Channel Blockers Phase 4
29 Anti-Arrhythmia Agents Phase 4
30 Diuretics, Potassium Sparing Phase 4
31 Anesthetics, Local Phase 4
32
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 2, Phase 3 1177-87-3
33
Dexamethasone Approved, Investigational, Vet_approved Phase 2, Phase 3 50-02-2 5743
34
Phenol Approved, Experimental Phase 2, Phase 3 108-95-2 996
35
tannic acid Approved Phase 2, Phase 3 1401-55-4
36
Benzocaine Approved, Investigational Phase 2, Phase 3 94-09-7, 1994-09-7 2337
37 Pharmaceutical Solutions Phase 2, Phase 3
38
Prednisone Approved, Vet_approved Phase 2 53-03-2 5865
39
Prilocaine Approved 721-50-6 4906
40
Salicylic acid Approved, Investigational, Vet_approved 69-72-7 338
41
Clotrimazole Approved, Vet_approved 23593-75-1 2812
42
Miconazole Approved, Investigational, Vet_approved 22916-47-8 4189
43
Lapatinib Approved, Investigational Early Phase 1 231277-92-2, 388082-78-8 208908 9941095
44
Iron Approved, Experimental 15438-31-0, 7439-89-6 27284 23925
45 Insulin, Globin Zinc
46 insulin
47 Dermatologic Agents
48 Antifungal Agents
49 Keratolytic Agents
50 Vaccines

Interventional clinical trials:

(show top 50) (show all 83)
# Name Status NCT ID Phase Drugs
1 A Multicentre Placebo-Controlled Evaluation of Prednisolone and/or Valaciclovir for the Treatment of Bell's Palsy Completed NCT00510263 Phase 4 Prednisolone + placebo;Valaciclovir + placebo;Prednisolone + valaciclovir;Placebo + placebo
2 Randomized, Single-blind Comparison of Three Commercially Available Botulinum Neuromodulators in the Management of Facial Synkinesis Completed NCT03048383 Phase 4 OnabotulinumtoxinA Injectable Product;AbobotulinumtoxinA Injectable Product;Incobotulinumtoxin A Injectable Product
3 The Facial Nerve Palsy And Cortisone Evaluation (FACE) Study in Children: A Randomized Double-blind, Placebo-controlled, Multicenter Trial Recruiting NCT03781700 Phase 4 Prednisolone;Placebo Oral Tablet
4 Do We Need to Taper Down Steroid Therapy for Bell's Palsy: A Prospective Randomized Controlled Trial Recruiting NCT04406376 Phase 4 Prednisone tablet
5 Mixed Methods Investigation of Chronic Facial Paralysis in Individuals With Synkinesis: Study of Outcomes Before and After Treatment Enrolling by invitation NCT04148872 Phase 4 Chemodenervation (4 months)
6 Study of the Reinnervation of Facial Muscles After Lengthening Temporalis Myoplasty Terminated NCT01833221 Phase 4 injection of 1% lidocaine, 2mL for facial nerve block
7 Assessment of Corticosteroid Effect in the Prevention of Facial Palsy After Cerebella-pontine Angle Surgery Completed NCT00438087 Phase 3 methylprednisolone
8 Intratympanic Steroid Injection for Treatment of Idiopathic Facial Nerve Paralysis Recruiting NCT03508440 Phase 2, Phase 3 Prednisone
9 Quadrant Parotidectomy Versus Superficial Parotidectomy for Treatment of Pleomorphic Adenoma Withdrawn NCT01607866 Phase 2, Phase 3
10 Prednisone Treatment for Vestibular Neuronitis Completed NCT00271791 Phase 2 Prednisone;Prednisone
11 Mimetic Interfaces - Toispuoleisen Kasvohermohalvauksen Kojeellinen Kuntoutus Terveen Puolen Lihasaktiviteettiohjauksella. Stimulaattorin Prototyypin Testaus terveillä koehenkilöillä ja Kasvohermohalvauspotilailla. Active, not recruiting NCT03496025 Phase 1
12 Intratympanic Stereoidal Injections for Facial Nerve Palsy Unknown status NCT03371589 Dexamethasone
13 Surgery or Clinical Follow-up in Patients With Bell's Palsy. A Prospective, Parallell, Single Center, Randomized , Open Surgery Clinical Study. Unknown status NCT02179684
14 Study of Psychological Factors on the Occurence of Bell's Palsy Unknown status NCT01377766
15 Prednisone Acetate and Acupuncture for the Treatment of Facial Neuritis: a Multiple Center, Comparative Effectiveness Research in China Unknown status NCT01201642 Prednisolone
16 Lengthening Temporalis Myoplasty and Improvement of Primary Swallowing Disorders in Facial Paralysis Unknown status NCT03284125
17 Validation of a French-language Version of Specific Quality of Life Questionnaires in Patients With Peripheral Facial Palsy Unknown status NCT03581253
18 The Safety of GSK Biological's H1N1 Pandemic Vaccine in Manitoba, Canada Unknown status NCT01421251
19 Imaging of Facial Neuritis Using T2-weighted Gradient-echo Fast Imaging Employing Steady State Acquisition After Gadolinium Injection Unknown status NCT03543384
20 Quantification, Analysis and Simulation of Facial Mimics Movements Unknown status NCT02002572
21 Prospective Randomized Study Comparing Clinical, Functional and Aesthetics Results of "Classical" Pterional and Minipterional Craniotomies. Unknown status NCT01872741
22 Cognitive and Physical Functions in Patients With TIA. A Randomized Controlled Trial of Physical Activity on Prescription up to One Year After the Event Unknown status NCT01509924
23 Evaluation of Acquired Punctal Stenosis by Using Anterior Segment Optical Coherence Tomography (AS-OCT) Unknown status NCT03498144
24 EFFECTIVENESS OF PULSED ULTRASOUND TREATMENT ON PATIENT WITH BELL'S PALSY, A DOUBLE-BLIND, RANDOMİZED, PLACEBO-CONTROLLED TRIAL Completed NCT04412733
25 Studying of Acupuncture for Bell's Palsy According to Different Stages Completed NCT00608660
26 Microbiologic Findings of Acute Facial Palsy in Children Completed NCT01537952
27 Study of Effects of Deqi and Neuropsychological Factors on Acupuncture Effects in Treatment of Bell's Palsy Completed NCT00685789
28 A New Clinical Therapy for Bell's Palsy Completed NCT01686464 prednisone and valacyclovir treatments
29 Function and Form Outcomes in Patients With Facial Paralysis Completed NCT03974763
30 Assessment of the Cross-face Nerve Graft in the Treatment of Facial Paralysis Completed NCT03006783
31 Treatment Bell´s Palsy: Prednisone vs Prednisone Valacyclovir Completed NCT00561106 prednisone- valacyclovir;prednisone-placebo
32 The Role of MyotonPro in Assessing the Biomechanical Properties of Facial Muscles in Facial Paralysis Patients and Its Role in Monitoring Recovery Following Facial Reanimation Surgery Completed NCT02489162
33 Improvement of Facial Symmetry With Myofunctional Therapy Combined to Botulinum Toxin Injections in Long Standing Facial Paralysis Completed NCT00989209 Botulinum Toxin Type A
34 The Role of Collagen in the Rehabilitation of Peripheral Paralysis of the Facial Nerve Completed NCT04353908
35 Pilot Study Assessing Cognitive Function and Emotional Possessing in Patients With Bilateral Facial Palsy Completed NCT02179450
36 Antiviral Treatment in Facial Palsy. Randomized Control Trial Completed NCT02328079 Steroids (Prednisolone) and Steroids plus Antiviral (Prednisolone + acyclovir)
37 Anthropometric Angular Measurement to Determine Muscle Tonus in Patients With Peripheral Facial Paralysis Completed NCT00903669
38 Post-parotidectomy Facial Paresis: Intraoperative and Postoperative Factors Completed NCT02527226
39 Neuro Occlusal Rehabilitation in Patient With Peripheral Facial Paralysis - a Randomized Clinical Trial Completed NCT01327157
40 A Phase IV Study to Assess the Safety of Menveo Vaccine Being Used by HMO Subjects Aged 11-21 Years of Age Completed NCT01452464
41 Complications in Parotid Surgery - a Prospective Cohort Study Completed NCT02486393
42 Non-surgical Correction of Eye Lid Paralysis With External Magnet Systems Completed NCT02988856
43 A New Predictor Marker for Cochlear Implants Infection: Neutrophil/ Lymphocyte Ratio Completed NCT04120181
44 Retrospective Clinical Outcome of Parotid Tumor Surgery Completed NCT01983176
45 Clinical Research Core Dental Screening Protocol Completed NCT00090818
46 Exploration of the Diagnostic Capabilities of Ultrasound of the Oropharynx and Larynx Completed NCT00001167
47 Validation of Prehospital Stroke Scale (FAST PLUS TEST) to Predict Patients With Large Arterial Vessel Intracranial Occlusion. Completed NCT03072524
48 Exploration and Estimation of Intratumoral Concentration and Activity of Lapatinib in Vivo in Vestibular Schwannomas Completed NCT00863122 Early Phase 1 lapatinib
49 Study on Moebius Syndrome and Other Congenital Facial Weakness Disorders Completed NCT02055248
50 Assessment Effects of Somatosensorial and Vestibular Rehabilitation Additional Conventional Therapy on Balance in Patients With Acute Stroke Completed NCT03477188

Search NIH Clinical Center for Bell's Palsy

Inferred drug relations via UMLS 71 / NDF-RT 50 :


Scopolamine
Scopolamine Hydrobromide

Cochrane evidence based reviews: bell palsy

Sources

Genetic Tests for Bell's Palsy

About this section

Genetic tests related to Bell's Palsy:

# Genetic test Affiliating Genes
1 Facial Palsy 29
Sources

Anatomical Context for Bell's Palsy

About this section

MalaCards organs/tissues related to Bell's Palsy:

40
Eye, Testes, Bone, Neutrophil, Brain, Skin, T Cells
Sources

Publications for Bell's Palsy

About this section

Articles related to Bell's Palsy:

(show top 50) (show all 2447)
# Title Authors PMID Year
1
The association between Bell's palsy and rheumatoid arthritis: A longitudinal study. 61 42
32195966 2020
2
Neuromuscular electrical stimulation and shortwave diathermy in unrecovered Bell palsy: A randomized controlled study. 61 42
32080092 2020
3
Bell's Palsy in Pregnancy. 42 61
31755544 2019
4
Herbal medicine for treating Bell's palsy: A retrospective chart review. 61
32435585 2020
5
Effect of Thick-Needle Therapy in Patients with Bell's Palsy at Recovery Stage: A Multi-center Randomized Controlled Trial. 61
32291607 2020
6
Nasolabial Fold Dynamics: Implications for Facial Paralysis and Facial Reanimation Surgery. 61
32543100 2020
7
Concentrations of Serum Cyclophilin A in Patients With Bell Palsy. 61
32149981 2020
8
Effectiveness comparisons of acupuncture treatments for Bell palsy in adults: A protocol for systematic review and Bayesian network meta-analysis. 61
32501973 2020
9
Nerve Integrity Monitor Responses to Direct Facial Nerve Stimulation During Facial Nerve Decompression Surgery Can Predict Postoperative Outcomes. 61
32080029 2020
10
Potential Confounding Factors May Influence the Association Between Configurations of the Vertebrobasilar System and the Incidence of Idiopathic Sudden Sensorineural Hearing Loss and Canal Paresis. 61
32150021 2020
11
The Efficacy of Electro-Acupuncture Added to Standard Therapy in the Management of Bell Palsy. 61
32472874 2020
12
Facial Nerve Palsy: Clinical Practice and Cognitive Errors. 61
32445717 2020
13
Acupuncture as Part of Iatrogenic Facial Nerve Palsy Rehabilitation-First Report. 61
32434036 2020
14
Degree of Self-Reported Facial Impairment Correlates with Social Impairment in Individuals with Facial Paralysis and Synkinesis. 61
32407141 2020
15
Submental and Anterior Neck Originated Full-Thickness Skin Grafts for Periocular Procedures. 61
31743277 2020
16
Sydney Facial Nerve Clinic: experience of a multidisciplinary team. 61
32129559 2020
17
Predictive Values of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Other Prognostic Factors in Pediatric Patients With Bell's Palsy. 61
32364446 2020
18
Prognostic factors for the outcome of Bells' palsy: A cohort register-based study. 61
32395899 2020
19
[Discussion on refractory factors of Bell's palsy and clinical experience in treatment]. 61
32394664 2020
20
Quality of Life in Bell's Palsy: Correlation with Sunnybrook and House-Brackmann Over Time. 61
32463963 2020
21
Compressive Neuropathy of the Facial Nerve Presenting as Bell's Palsy in a Pediatric Patient on High-Frequency Oscillatory Ventilation. 61
32542146 2020
22
Consensus statement. Corticosteroid therapy in ENT in the context of the COVID-19 pandemic. 61
32482571 2020
23
ACR Appropriateness Criteria® Cerebrovascular Disease-Child. 61
32370977 2020
24
Intratympanic Steroid Treatment of Bell's Palsy in Patients with Comorbid Disease: A Preliminary Report. 61
31287437 2020
25
Efficacy of low-level laser therapy on management of Bell's palsy: a systematic review. 61
32318918 2020
26
Review of the initial post-marketing safety surveillance for the recombinant zoster vaccine. 61
31818534 2020
27
Etiology and therapy of delayed facial paralysis after middle ear surgery. 61
32008076 2020
28
Ramsay Hunt syndrome: characteristics and patient self-assessed long-term facial palsy outcome. 61
31982948 2020
29
Computer vision technology-based face mirroring system providing mirror therapy for Bell's palsy patients. 61
30634878 2020
30
Facial paralysis: Clinical practice guideline of the Spanish Society of Otolaryngology. 61
31097197 2020
31
Air pollution by NO2 is associated with the risk of Bell's palsy: A nested case-controlled study. 61
32144358 2020
32
Bell's palsy and obesity, alcohol consumption and smoking: A nested case-control study using a national health screening cohort. 61
32144385 2020
33
Status of Lactate Dehydrogenase, Neutrophil-lymphocyte Ratio, Mean Platelet Volume, and Platelet-lymphocyte Ratio in Bell's Palsy. 61
32351812 2020
34
Beyond Botox: Contemporary Management of Nonflaccid Facial Palsy. 61
32130060 2020
35
Case report: cardiac herniation following robotic-assisted thymectomy. 61
32228645 2020
36
Variations in the morphology of stylomastoid foramen: A possible solution to the conundrum of unexplained cases of Bell's palsy. 61
32073133 2020
37
[Early treatment of suspension moxibustion for Bell's palsy in acute stage]. 61
32100495 2020
38
Suprazygomatic Aponeurotic McLaughlin Myoplasty: Facial Reanimation Made Simpler! 61
32049759 2020
39
Isolated peripheral-type facial palsy due to contralateral precentral gyrus cavernoma hemorrhage. 61
31982278 2020
40
Give me a kiss! An integrative rehabilitative training program with motor imagery and mirror therapy for recovery of facial palsy. 61
30916916 2020
41
The Utility of Facial Nerve Ultrasonography in Bell's Palsy. 61
31870206 2020
42
Efficacy of electrotherapy in Bell's palsy treatment: A systematic review. 61
32144972 2020
43
Factors Associated With Fast Recovery of Bell Palsy in Children. 61
31623512 2020
44
Evaluation of Factors Associated With Favorable Outcomes in Adults With Bell Palsy. 61
31971554 2020
45
A case of a facial nerve venous malformation presenting with crocodile tear syndrome. 61
31966922 2020
46
Facial Weakness Analysis and Quantification Of Static Images. 61
31944968 2020
47
Implantable wireless device for study of entrapment neuropathy. 61
31626845 2020
48
Pregnancy Does Not Increase the Risk of Bell's Palsy: A National Cohort Study. 61
31789796 2020
49
Is C-reactive protein to albumin ratio an indicator of poor prognosis in Bell's palsy? 61
31620889 2020
50
Complete and Fast Recovery from Idiopathic Facial Paralysis Using Laser-Photobiomodulation. 61
32231809 2020
Sources

Variations for Bell's Palsy

About this section

ClinVar genetic disease variations for Bell's Palsy:

6 ‎‎
# Gene Name Type Significance ClinVarId dbSNP ID GRCh37 Pos GRCh38 Pos
1 46;XX;t(1;13)(q11.2;p11.2)dnTranslocation Uncertain significance 267932
Sources

Expression for Bell's Palsy

About this section
Search GEO for disease gene expression data for Bell's Palsy.
Sources

Pathways for Bell's Palsy

About this section

Pathways related to Bell's Palsy according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
NF-kappaB Signaling 4
12.18 IL2RA IFNA1 CD8A CD40LG
2
Allograft rejection 1 36
Show member pathways
 12.1 IL2RA IFNA1 CD8A CD40LG CD4
3
Hematopoietic Stem Cells and Lineage-specific Markers 64
11.64 IL2RA CD8A CD4
4
IL12-mediated signaling events 1
Show member pathways
 11.55 IL2RA CD8A CD4
5
Hematopoietic cell lineage 36
11.43 IL2RA CD8A CD4
6
Innate Lymphoid Cells Differentiation 64
11.23 IL2RA CD8A CD4
7
Primary immunodeficiency 36
10.38 CD8A CD40LG CD4
Sources

GO Terms for Bell's Palsy

About this section

Biological processes related to Bell's Palsy according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 immune response GO:0006955 9.72 IL2RA DEFA1 CD8A CD40LG CD4
2 defense response to Gram-negative bacterium GO:0050829 9.54 DEFA3 DEFA1 CD4
3 positive regulation of T cell proliferation GO:0042102 9.33 IL2RA CD40LG CD4
4 membrane disruption in other organism GO:0051673 9.26 DEFA3 DEFA1
5 defense response to virus GO:0051607 9.26 MX1 IFNA1 DEFA3 DEFA1
6 defense response GO:0006952 8.92 MX1 IFNA1 DEFA3 DEFA1
Sources

Sources for Bell's Palsy

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....